's single product that passed consistency evaluation received a grant of 6 million, on the April 18th, Gansu, Shanghai, and Liaoning Provinces sent welfare
to generic drugs that passed consistency evaluation!
On the 18th, Gansu Province issued a notice requiring grass-roots medical institutions to give priority to the purchase of generic drugs that have passed the consistency evaluation of quality and efficacy to replace the branded drug!
▍Products passing consistency evaluation were formally linked to online procurement
On April 18, the Gansu Health and Family Planning Commission issued a notice to make a request for strengthening the supply and use management of grass-roots medicines.
The notice requires that grass-roots medical institutions give priority to the purchase of generic drugs that have passed the consistency evaluation of quality and efficacy to replace the branded drug, use more commonly used low-priced medicines, and strictly control the ratio of non-essential medicines. It is strictly prohibited to abuse non-therapeutic adjuvant drugs that damage the patient's interests or increase the patient's burden and was limited to use.
On the same day, the Shanghai Sunshine Pharmaceutical Procurement Platform promulgated the "Notice on the Promulgation of the Second Batch of Products Approved via the Consistency Evaluation of the Quality and Efficacy of the Generic Drugs in the 2018 Year."
Notice Announced that 19 products such as Taijia (Closopram Sulfate Tablets) from Shenzhen Xinglitai, Leyou (hydrochloride paroxetine hydrochloride tablets) and Sola (Risperidone Hydrochloride Tablets) from Zhejiang Huahai Pharmaceutical Co., Ltd. are directly linked to the network, and medical institutions can negotiate to purchase.
Also on the 18th, the Liaoning Drug Procurement Office issued the "Circular on Launching Direct Procurement for Newly Approved Innovative Drugs and Generic Drugs Passed Consistency Evaluation of Quality and Curative Effect".
The notice clearly states that the drugs that have been issued by CDE and have passed the conformity assessment and meet the relevant requirements deemed to have passed the consistency evaluation and have not participated in the centralized procurement of drugs in Liaoning Province. They can submit applications from the 20th to the 28th of this month.
▍Equivalent to the treatment of branded drug
In accordance with the requirements of the General Office of the State Council, a number of announcements were issued to encourage medical institutions to purchase and use products that passed consistency evaluation.
On April 11th, the Heilongjiang Health and Family Planning Commission issued the "Notice on Further Reforming and Perfecting the Specific Opinions on Drug Production, Distribution, and Use Policy," which mentioned that it is necessary to implement the priority clinical policy for drug passed consistency evaluation . For medicines that passed consistency evaluation, medical institutions at all levels must give priority to procurement and clinical use.
If there are more than 3 enterprises for drugs of the same category have passed consistency evaluation, drug procurement and medical and health institutions will will no longer use varieties that have not passed consistency evaluation.
On March 6, Shanxi issued a notice to encourage medical institutions to procure and use products that have passed consistency evaluation. Each procurement consortium and medical institutions at all levels must incorporate them into the list of drugs that can be substituted for branded drugs, and give them priority to procurement and use.
On January 25th, Jiangsu Province stipulated that the generic drugs that passed the consistency evaluation within the current cycle of centralized drug procurement should enjoy the same treatment as the branded drugs. and allow the current price of the provincial procurement platform to remain unchanged. However, the company must commit that the selling price of this product in Jiangsu is not higher than other provinces.
On January 29, the Shanghai Sunshine Pharmaceutical Purchasing Network issued a notice to encourage medical institutions to procure and use products that have passed consistency evaluation and require a direct online procurement. It is required that bargaining results of the varieties passed consistency evaluation should generally not be higher than 70% of the price of the branded drugs or reference preparation.
According to the Opinions on the Consistency Evaluation of Generic Drugs Quality and Efficacy Released by the General Office of the State Council in February 2016, drugs that have passed the generic consistency evaluation also entitled to be announced by the drug regulatory department to the public, and the drug instruction manuals and labels are marked. Medical institutions should prioritize procurement, prioritize clinical use, and apply for benefits such as central infrastructure investment and industrial fund support.
With regard to financial support, many provinces and cities have introduced clear awards and subsidy policy, with a maximum reward of 3 million.
Zibo: One-time reward of 2 million
Zhejiang: One-time bonus of 3 million
Gansu: 3 million subsidies for each species
Anhui: One-time bonus of 1 million, up to 3 million
Luzhou: Give 6 million rewards at one time
Jiangxi 500,000 - 1,000,000 Awards
Haikou: Up to 3 million rewards